Navigation Links
Centocor Ortho Biotech Inc. Submits Application to FDA Seeking to Expand SIMPONI® Label to Include Inhibition of Structural Damage in Treatment of Psoriatic Arthritis
Date:11/11/2010

0;For additional information on psoriatic arthritis, visit the National Psoriasis Foundation.

About SIMPONI

SIMPONI is a human monoclonal antibody that targets and neutralizes excess TNF-alpha, a protein that when overproduced in the body due to chronic inflammatory diseases can cause inflammation and damage to bones, cartilage and tissue. A once-monthly subcutaneous anti-TNF-alpha therapy with marketing authorizations in the Unites States, Europe and Canada, SIMPONI is approved for the treatment of moderately to severely active RA in combination with methotrexate, active PsA and active AS.  SIMPONI is available either through the SIMPONI SmartJect® autoinjector or a prefilled syringe.  For more information about SIMPONI, visit www.SIMPONI.com.  

Centocor Ortho Biotech Inc. discovered and developed SIMPONI and has exclusive marketing rights to the product in the United States.

Important Safety Information

SIMPONI® (golimumab) is a prescription medicine. SIMPONI® can lower your ability to fight infections. There are reports of serious infections caused by bacteria, fungi, or viruses that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor will test you for TB before starting SIMPONI® and will monitor you for signs of TB during treatment. Tell your doctor if you have been in close contact with people with TB. Tell your doctor if you have been in a region (such as the Ohio and Mississippi River Valleys and the Southwest) where certain fungal infections like histoplasmosis or coccidioidomycosis are common.

You should not start SIMPONI® if you have any kind of infection. Tell your doctor if you are prone to or have a history of infections or have
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotechs New Psoriasis Agent Stelara (ustekinumab) is High
2. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
3. Chesley Files Class Action Against DePuy Orthopaedics
4. Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of SOFTISSUE - The Issue of Soft Tissue, Featuring James J. Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of Califor
5. Hanger Orthopedic Group, Inc. Announces Early Tender Results of Offer to Purchase Outstanding 10-1/4% Senior Notes Due 2014
6. Local Chinese Government Authorities Approve Pricing and Reimbursement for NeoStems Licensed Adult Stem Cell Treatments for Orthopedic Applications in China
7. New Orthopedic Market Research Data Covering Multiple Geographies Released by Millennium Research Group
8. Merlot OrthopediX Enters into Exclusive Global Agreement with Alphatec Spine to Develop and Market Merlots Bone Anchorage Technology for the Treatment of Spine Disorders
9. Hanger Orthopedic Group, Inc. Announces Pricing of $200 Million of Senior Notes
10. Hanger Orthopedic Group Signs Definitive Merger Agreement To Acquire Accelerated Care Plus
11. Hanger Orthopedic Group Announces Preliminary Third Quarter Revenue and Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)...  New York College of Health Professions announces a ... with U.S. Patent #8,996,098 donated by its Chairman under ... surgical instrument that allows surgeons to view and compare ... the traditional format of a slide that is used ... surgery, thus providing the surgeon real time analysis and ...
(Date:4/1/2015)... Morgan & Morgan, P.C. announces that it ... of Auspex Pharmaceuticals, Inc. ("Auspex" or the "Company") (NasdaqGS: ... and other violations of state law related to the ...  The transaction is valued at approximately $3.5 billion. ... like to learn more about the Auspex investigation ...
(Date:4/1/2015)... , Mar. 31, 2015 Research and ... the addition of the "Metabolic Testing Market ... System), by Application (Critical Care, Lifestyle Diseases), by ... (Gym, Sports, Hospital) - Global Forecast to 2019 ... The global metabolic testing market is expected to ...
Breaking Medicine Technology:Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Global Metabolic Testing (CPET, Body Composition Analysis, ECG, Portable System) Market 2015-2019 - REE, Body Composition Analysis for Gyms, Sports & Hospital 2
... 1, 2011 Vermillion, Inc. (NASDAQ: VRML ), ... lead a new investor relations and financial communications program. ... blood test and the recent positive results from our peripheral ... progress since the beginning of the year," said Gail Page, ...
... Merz Aesthetics, Inc., the exclusive distributor of Asclera® (polidocanol) ... the "STAND AND DELIVER" program.  In partnership with an ... their significant abilities to STAND AND DELIVER, this initiative ... by making a difference in their communities. Finalists and ...
Cached Medicine Technology:Vermillion Engages Liolios Group to Lead Investor Relations Program 2Vermillion Engages Liolios Group to Lead Investor Relations Program 3Merz Aesthetics and Inspirational Women Join Forces to Recognize Women Who STAND AND DELIVER 2Merz Aesthetics and Inspirational Women Join Forces to Recognize Women Who STAND AND DELIVER 3
(Date:4/1/2015)... Peoria, Ill. (PRWEB) April 01, 2015 ... the OSF Healthcare System , was welcomed into ... Dedication Ceremony officiated by Msgr. Paul E. Showalter, vicar ... , The Blessing and Dedication culminated a nearly year-long ... the eleventh OSF HealthCare hospital. Speakers for the morning ...
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 ... senior care, today announces the launch of the ... innovative senior care stakeholders and technology companies. The announcement ... Center (NIC) Capital and Business Strategies Forum in ... members, the new Alliance program is now open for ...
(Date:4/1/2015)... Dr. Rod J. Rohrich , Dallas ... Department of Plastic Surgery at UT Southwestern Medical Center, ... blindness resulting from the use of facial aesthetic ... study, along with ideas for treatment and prevention in ... to see increasing reports of blindness as a result ...
(Date:4/1/2015)... GA (PRWEB) April 01, 2015 ... Medicine Practice, Pediatric Emergency Medicine Practice, and Hospital ... has partnered with AgileMD to provide the content ... , in a mobile application format available on ... , “Our collaboration with AgileMD to develop mobile ...
(Date:4/1/2015)... 2015 Skin cancer is one of the ... caught early. Forefront Dermatology and Dermatology Associates of Wisconsin want ... before it spreads so they are hosting a free skin ... 8:30am - 12:30pm. , “If we can see the ... concern, that could become cancerous,” said Dr. Ken Katz, who ...
Breaking Medicine News(10 mins):Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 2Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 3Health News:Forefront Dermatology and Dermatology Associates of Wisconsin Offers Skin Cancer Screenings on April 11th 2
... for patients with the Anakam Identity Suite(R) , ... that Sharp HealthCare, San Diego County,s largest healthcare system, ... access for patients accessing Sharp,s new patient portal. ... meet the needs of its patient community by providing ...
... , FORT LAUDERDALE, Fla., June 24 Argentech, Inc. ... reached agreement with Invision International Health Solutions, Inc., to ... antiviral technology that utilizes ionic silver in a unique ... complex was granted broad patent protection in the U.S. ...
... Cancer Institute scientists, discovery of a cancer-causing gene the ... demonstrates how the panoramic view of genomics and the close-up ... are involved in cancer and which are mere bystanders. The ... journal Nature . "In the coming years, we ...
... Minn., June 24 The Mayo Clinic Center for ... on innovations in health care experience and delivery, Sept. ... the public. It will feature nationally recognized speakers on ... care delivery models, including Web-based tools. The center,s work ...
... study finds , WEDNESDAY, June 24 (HealthDay News) -- ... taking drugs to prevent osteoporosis is unnecessary and could ... Australian researchers analyzed data from a large randomized trial ... widely used bisphosphonate) in more than 6,000 postmenopausal women ...
... 24, 2009 Furthering its mission to improve ... (USP) Convention has signed a cooperative agreement with ... Asian Nations (ASEAN). In a drive to strengthen ... control laboratories, officials from Cambodia, Laos, Myanmar, Singapore, ...
Cached Medicine News:Health News:Sharp HealthCare and Anakam(R) Partner to Protect Patients' Health Information 2Health News:Sharp HealthCare and Anakam(R) Partner to Protect Patients' Health Information 3Health News:Potential Silver Bullet for Swine Flu and Most Common Infections Using Green Technology Patented in U.S. and Mexico 2Health News:Potential Silver Bullet for Swine Flu and Most Common Infections Using Green Technology Patented in U.S. and Mexico 3Health News:Study pinpoints novel cancer gene and biomarker 2Health News:Study pinpoints novel cancer gene and biomarker 3Health News:Study pinpoints novel cancer gene and biomarker 4Health News:Mayo Clinic Center for Innovation to Sponsor a Collaborative Symposium on Innovations in Health Care Experience and Delivery 2Health News:Mayo Clinic Center for Innovation to Sponsor a Collaborative Symposium on Innovations in Health Care Experience and Delivery 3Health News:Bone Therapy May Not Always Need Monitoring 2Health News:Goal of good quality medicines advanced by new USP agreement with 9 ASEAN countries 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: